Good publication practice for pharmaceutical companies

SUMMARY Guidelines on Good Publication Practice (GPP) for pharmaceutical companies are presented. The aim of the guidelines is to ensure that clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner. The guidelines cover companies' responsibility t...

Full description

Saved in:
Bibliographic Details
Published in:Current medical research and opinion 2003, Vol.19 (3), p.149-154
Main Authors: Wager, Elizabeth, Field, Elizabeth A., Grossman, Leni
Format: Article
Language:English
Subjects:
Biological and medical sciences
Drug Industry
Good publication practice
Guidelines as Topic
Medical sciences
Peer review
Pharmaceutical industry
Publications - standards
Scientific Misconduct
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:SUMMARY Guidelines on Good Publication Practice (GPP) for pharmaceutical companies are presented. The aim of the guidelines is to ensure that clinical trials sponsored by pharmaceutical companies are published in a responsible and ethical manner. The guidelines cover companies' responsibility to endeavour to publish results of all studies, companies' relations with investigators, measures to prevent redundant or premature publication, methods to improve trial identification and the role of professional medical writers. Our aim in publishing the GPP guidelines, which are the first to be developed by and for those working on publications in the pharmaceutical industry, is to stimulate discussion between journals, investigators and trial sponsors and to provide guidance to those who seek it. We also hope that pharmaceutical companies and others involved in developing publications arising from sponsored clinical trials will endorse the guidelines.
ISSN:0300-7995
1473-4877
DOI:10.1185/030079903125001767